Logo image of FRPT

FRESHPET INC (FRPT) Stock Fundamental Analysis

NASDAQ:FRPT - US3580391056 - Common Stock

62.62 USD
+2.17 (+3.59%)
Last: 8/22/2025, 8:10:31 PM
62.6 USD
-0.02 (-0.03%)
After Hours: 8/22/2025, 8:10:31 PM
Fundamental Rating

4

FRPT gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 90 industry peers in the Food Products industry. FRPT scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. FRPT is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

FRPT had positive earnings in the past year.
FRPT had a positive operating cash flow in the past year.
FRPT had negative earnings in 4 of the past 5 years.
FRPT had a positive operating cash flow in 4 of the past 5 years.
FRPT Yearly Net Income VS EBIT VS OCF VS FCFFRPT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M -300M

1.2 Ratios

FRPT has a Return On Assets (2.04%) which is in line with its industry peers.
The Return On Equity of FRPT (3.14%) is comparable to the rest of the industry.
FRPT has a Return On Invested Capital (2.84%) which is in line with its industry peers.
Industry RankSector Rank
ROA 2.04%
ROE 3.14%
ROIC 2.84%
ROA(3y)-1.53%
ROA(5y)-1.83%
ROE(3y)-1.62%
ROE(5y)-1.96%
ROIC(3y)N/A
ROIC(5y)N/A
FRPT Yearly ROA, ROE, ROICFRPT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 -2 4 -4

1.3 Margins

Looking at the Profit Margin, with a value of 3.23%, FRPT is in the better half of the industry, outperforming 61.80% of the companies in the same industry.
The Operating Margin of FRPT (5.38%) is comparable to the rest of the industry.
Looking at the Gross Margin, with a value of 40.87%, FRPT belongs to the top of the industry, outperforming 93.26% of the companies in the same industry.
In the last couple of years the Gross Margin of FRPT has declined.
Industry RankSector Rank
OM 5.38%
PM (TTM) 3.23%
GM 40.87%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.84%
GM growth 5Y-2.62%
FRPT Yearly Profit, Operating, Gross MarginsFRPT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

More info and screens

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), FRPT is destroying value.
Compared to 1 year ago, FRPT has more shares outstanding
Compared to 5 years ago, FRPT has more shares outstanding
The debt/assets ratio for FRPT has been reduced compared to a year ago.
FRPT Yearly Shares OutstandingFRPT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
FRPT Yearly Total Debt VS Total AssetsFRPT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

FRPT has an Altman-Z score of 3.93. This indicates that FRPT is financially healthy and has little risk of bankruptcy at the moment.
FRPT has a better Altman-Z score (3.93) than 79.78% of its industry peers.
A Debt/Equity ratio of 0.40 indicates that FRPT is not too dependend on debt financing.
With a Debt to Equity ratio value of 0.40, FRPT perfoms like the industry average, outperforming 52.81% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF N/A
Altman-Z 3.93
ROIC/WACC0.35
WACC8.05%
FRPT Yearly LT Debt VS Equity VS FCFFRPT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M 800M 1B

2.3 Liquidity

FRPT has a Current Ratio of 4.81. This indicates that FRPT is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 4.81, FRPT belongs to the top of the industry, outperforming 93.26% of the companies in the same industry.
A Quick Ratio of 3.75 indicates that FRPT has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 3.75, FRPT belongs to the best of the industry, outperforming 94.38% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.81
Quick Ratio 3.75
FRPT Yearly Current Assets VS Current LiabilitesFRPT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

7

3. Growth

3.1 Past

FRPT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 104.00%, which is quite impressive.
FRPT shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 19.30%.
Measured over the past years, FRPT shows a very strong growth in Revenue. The Revenue has been growing by 31.72% on average per year.
EPS 1Y (TTM)104%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%1200%
Revenue 1Y (TTM)19.3%
Revenue growth 3Y31.84%
Revenue growth 5Y31.72%
Sales Q2Q%12.51%

3.2 Future

The Earnings Per Share is expected to grow by 33.75% on average over the next years. This is a very strong growth
FRPT is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 13.63% yearly.
EPS Next Y37.41%
EPS Next 2Y53.01%
EPS Next 3Y42.98%
EPS Next 5Y33.75%
Revenue Next Year13.92%
Revenue Next 2Y13.65%
Revenue Next 3Y13.3%
Revenue Next 5Y13.63%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
FRPT Yearly Revenue VS EstimatesFRPT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 500M 1B 1.5B 2B 2.5B
FRPT Yearly EPS VS EstimatesFRPT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 2 4 6 8

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 61.39, which means the current valuation is very expensive for FRPT.
Compared to the rest of the industry, the Price/Earnings ratio of FRPT is on the same level as its industry peers.
The average S&P500 Price/Earnings ratio is at 27.24. FRPT is valued rather expensively when compared to this.
A Price/Forward Earnings ratio of 28.46 indicates a quite expensive valuation of FRPT.
FRPT's Price/Forward Earnings is on the same level as the industry average.
FRPT's Price/Forward Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 22.81.
Industry RankSector Rank
PE 61.39
Fwd PE 28.46
FRPT Price Earnings VS Forward Price EarningsFRPT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

FRPT's Enterprise Value to EBITDA is on the same level as the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 23.31
FRPT Per share dataFRPT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
FRPT's earnings are expected to grow with 42.98% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.64
PEG (5Y)N/A
EPS Next 2Y53.01%
EPS Next 3Y42.98%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for FRPT!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

FRESHPET INC

NASDAQ:FRPT (8/22/2025, 8:10:31 PM)

After market: 62.6 -0.02 (-0.03%)

62.62

+2.17 (+3.59%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)08-04 2025-08-04/bmo
Earnings (Next)11-03 2025-11-03/bmo
Inst Owners123.1%
Inst Owner Change0.95%
Ins Owners1.67%
Ins Owner Change5.47%
Market Cap3.05B
Analysts80.83
Price Target96.98 (54.87%)
Short Float %12.7%
Short Ratio4.55
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)71.37%
Min EPS beat(2)-9.66%
Max EPS beat(2)152.4%
EPS beat(4)2
Avg EPS beat(4)63.66%
Min EPS beat(4)-9.66%
Max EPS beat(4)152.4%
EPS beat(8)6
Avg EPS beat(8)129.33%
EPS beat(12)8
Avg EPS beat(12)85.96%
EPS beat(16)8
Avg EPS beat(16)40.44%
Revenue beat(2)0
Avg Revenue beat(2)-1.97%
Min Revenue beat(2)-3.16%
Max Revenue beat(2)-0.78%
Revenue beat(4)1
Avg Revenue beat(4)-1.59%
Min Revenue beat(4)-3.16%
Max Revenue beat(4)0.07%
Revenue beat(8)4
Avg Revenue beat(8)-0.08%
Revenue beat(12)6
Avg Revenue beat(12)0.14%
Revenue beat(16)7
Avg Revenue beat(16)-0.61%
PT rev (1m)-9.79%
PT rev (3m)-19.78%
EPS NQ rev (1m)5.25%
EPS NQ rev (3m)5.05%
EPS NY rev (1m)2.76%
EPS NY rev (3m)-1.44%
Revenue NQ rev (1m)-1.24%
Revenue NQ rev (3m)-8.73%
Revenue NY rev (1m)-1.48%
Revenue NY rev (3m)-1.65%
Valuation
Industry RankSector Rank
PE 61.39
Fwd PE 28.46
P/S 2.93
P/FCF N/A
P/OCF 21.04
P/B 2.85
P/tB 2.85
EV/EBITDA 23.31
EPS(TTM)1.02
EY1.63%
EPS(NY)2.2
Fwd EY3.51%
FCF(TTM)-0.14
FCFYN/A
OCF(TTM)2.98
OCFY4.75%
SpS21.4
BVpS21.97
TBVpS21.97
PEG (NY)1.64
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.04%
ROE 3.14%
ROCE 3.6%
ROIC 2.84%
ROICexc 3.37%
ROICexgc 3.37%
OM 5.38%
PM (TTM) 3.23%
GM 40.87%
FCFM N/A
ROA(3y)-1.53%
ROA(5y)-1.83%
ROE(3y)-1.62%
ROE(5y)-1.96%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.84%
GM growth 5Y-2.62%
F-Score8
Asset Turnover0.63
Health
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF N/A
Debt/EBITDA 3.06
Cap/Depr 184.01%
Cap/Sales 14.58%
Interest Coverage 6.25
Cash Conversion 104.51%
Profit Quality N/A
Current Ratio 4.81
Quick Ratio 3.75
Altman-Z 3.93
F-Score8
WACC8.05%
ROIC/WACC0.35
Cap/Depr(3y)442.82%
Cap/Depr(5y)604.48%
Cap/Sales(3y)29.67%
Cap/Sales(5y)41.38%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)104%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%1200%
EPS Next Y37.41%
EPS Next 2Y53.01%
EPS Next 3Y42.98%
EPS Next 5Y33.75%
Revenue 1Y (TTM)19.3%
Revenue growth 3Y31.84%
Revenue growth 5Y31.72%
Sales Q2Q%12.51%
Revenue Next Year13.92%
Revenue Next 2Y13.65%
Revenue Next 3Y13.3%
Revenue Next 5Y13.63%
EBIT growth 1Y247.04%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year385.92%
EBIT Next 3Y99.29%
EBIT Next 5Y60.88%
FCF growth 1Y96.77%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y666.43%
OCF growth 3Y519.17%
OCF growth 5Y56.72%